Rondo Therapeutics
About:
Rondo Therapeutics creates novel bispecific antibodies that activate the immune system to fight cancer.
Website: http://www.rondotx.com
Top Investors: Johnson & Johnson Innovation – JJDC, SV Health Investors, Novo Holdings, Canaan Partners, Red Tree Venture Capital
Description:
Rondo Therapeutics is a therapeutic antibody discovery and development that creates novel bispecific antibodies that activate the immune system to fight cancer. The company was founded in 2021 and is headquartered in Hayward, California.
Total Funding Amount:
$67M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Hayward, California, United States
Founded Date:
2019-12-09
Founders:
Nathan Trinklein, Shelley Force Aldred
Number of Employees:
51-100
Last Funding Date:
2022-03-02
IPO Status:
Private
Industries:
© 2025 bioDAO.ai